A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study is a phase Ib/II study to evaluate the efficacy, safety and tolerance of HLX43 combined with HLX07 or Serplulimab in patients with advanced or metastatic colorectal cancer failed or intolerance to standard first-line therapy
Epistemonikos ID: 539815f7f8e04ed5281ad480fe3a8d38497c7aec
First added on: Jan 23, 2026